(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-WGKSLMD7'); Medication Guide ``
Skip to Main
Danziten Logo
  • Full Prescribing Information
  • Medication Guide
  • Azurity Solutions
  • Connect With Us
  • For Patients

  • About Danziten®
  • Adherence & Food Restrictions
  • Pharmacokinetics
  • Safety
  • Dosing & Administration
  • Nilotinib Overview
  • Access
  • Full Prescribing Information
  • Medication Guide
  • Azurity Solutions
  • Connect With Us
  • For Patients
Danziten Logo
  • About Danziten®
  • Adherence & Food Restrictions
  • Pharmacokinetics
  • Safety
  • Dosing & Administration
  • Nilotinib Overview
  • Access
Danziten Logo
  • Full Prescribing Information
  • Medication Guide
  • Azurity Solutions
  • Connect With Us
  • For Healthcare Professionals

  • CML & Treatment Response
  • Staying on Track
  • About Danziten®
  • Treatment-free Remission
  • Taking Danziten®
  • Financial Resources
  • Full Prescribing Information
  • Medication Guide
  • Azurity Solutions
  • Connect With Us
  • For Healthcare Professionals
Danziten Logo
  • CML & Treatment Response
  • Staying on Track
  • About Danziten®
  • Treatment-free Remission
  • Taking Danziten®
  • Financial Resources
Azurity Logo
Terms of UsePrivacy PolicyWeb Accessibility PolicyContact Us

The information contained herein, including product information, is intended only for healthcare providers in the United States.
© 2025 Azurity Pharmaceuticals, Inc. All Rights Reserved. Danziten® is a registered trademark of Azurity Pharmaceuticals, Inc.
All trademarks referred to are the property of their respective owners. PP-DAN-5357-US-EN-v2 9/26

Tasigna® is a registered trademark of Novartis Pharmaceuticals Corporation.